Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society.
Katina AleksovskaAndrew D HersheyMarie DeenRoberto De IccoMi Ji LeeHans-Christoph DienerPublished in: Cephalalgia : an international journal of headache (2023)
The GRADE evidence summary tables provided will support author groups to write treatment guidelines for the prevention of migraine with mAb.